KANE BIOTECH INC (KNE.CA) Stock Income Statement
TSX-V:KNE - TSX Venture Exchange - CA4838092084 - Common Stock - Currency: CAD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.10M | 149.00K | 2.67M | 1.61M | 1.34M | |||
| Minority Interest Expense | 0.00 | 0.00 | -65.90K | 245.40K | N/A | |||
| Cost Of Goods | 1.04M | 39.50K | 1.26M | 1.04M | 814.70K | |||
| Gross Profit | 1.07M | 109.50K | 1.41M | 568.50K | 526.90K | |||
| Operating Expenses | 7.33M | 3.47M | 4.78M | 5.45M | 4.75M | |||
| Research and Development | 2.16M | 1.05M | 1.05M | 1.38M | 1.33M | |||
| Selling, General, and Administrative Expenses | 5.17M | 2.41M | 3.72M | 4.07M | 3.43M | |||
| Operating Income | -6.26M | -3.36M | -3.36M | -4.88M | -4.22M | |||
| Interest Income/Expense | -1.69M | -1.21M | -715.10K | -290.20K | -81.70K | |||
| Other Income/Expense | N/A | 3.80K | 254.90K | 323.80K | 460.10K | |||
| Income Before Taxes | -7.95M | -4.56M | -3.82M | -4.85M | -3.85M | |||
| Net Income | 2.22M | -5.03M | -3.89M | -4.60M | -3.85M | |||
| EBITDA | -6.06M | -3.12M | -3.10M | -4.70M | -4.15M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.01 | -0.04 | -0.03 | -0.04 | -0.04 | |||
| Statistics | ||||||||
| Gross Profit Margin | 50.80% | 73.49% | 52.96% | 35.36% | 39.27% | |||
| Profit Margin | 105.28% | -3378.59% | -145.78% | -286.39% | -286.67% | |||
| Operating Profit Margin | -297.51% | -2253.29% | -126.06% | -303.74% | -314.88% | |||
All data in CAD